New Guidance for Common Hair Loss Disorder

Дата публикации: 25-09-2026 00:00:00

Adults with severe alopecia areata, an autoimmune hair loss disorder that affects more than 7 million people in the US, should primarily be treated with oral Janus kinase (JAK) inhibitors, according to a consensus statement published in JAMA Dermatology.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Ученые разрабатывают лекарство от тяжелой формы облысения	0	8.21	28-09-2026
2	Ozempic and similar medicines increase risk of hair loss in men	0	7.72	03-09-2026
3	Safety and Effects of Gildeuretinol Acetate on Retinal Atrophic Lesions in Stargardt Disease	0	3.79	03-09-2026
4	Комбинированный подход: как пересадка волос сочетается с плазмотерапией, медикаментозным лечением и другими методами	0	5.57	24-09-2026
5	Nucala (mepolizumab) approved in China for use in adults with chronic obstructive pulmonary disease (COPD)	0	6.1	05-01-2026
6	Patient Information: Hodgkin Lymphoma	0	6.94	24-09-2026
7	GLP-1 Drugs Not the Most Effective Treatment for Obstructive Sleep Apnea	0	9.78	25-09-2026
8	Bepirovirsen accepted for regulatory review in Japan as a potential first-in-class treatment for chronic hepatitis B	0	10.98	26-02-2026
9	Exdensur (depemokimab) approved in China for the treatment of severe asthma	0	6.77	30-03-2026
10	National Alopecia Areata Foundation holding annual walk in Harrisburg for the first time	0	6.49	26-09-2026

Классификация: Наука. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 9.88. Источник: www.jamanetwork.com.